EN | RU
EN | RU

Help Support

Back

Hydroxychloroquine and azithromycin combination could be helpful to treat COVID-19 patients

Hydroxychloroquine and azithromycin combination could be helpful to treat COVID-19 patients Hydroxychloroquine and azithromycin combination could be helpful to treat COVID-19 patients
Hydroxychloroquine and azithromycin combination could be helpful to treat COVID-19 patients Hydroxychloroquine and azithromycin combination could be helpful to treat COVID-19 patients

What's new?

Combination therapy with hydroxychloroquine and azithromycin could be considered as an effective treatment option for COVID-19. 

As per a recent open-label non-randomized clinical trial conducted in France, the combination therapy with hydroxychloroquine and azithromycin reduced the viral load in COVID-19 patients.

As chloroquine and hydroxychloroquine were reported to be effective in COVID-19 patients by China, this study was conducted to assess the role of hydroxychloroquine and azithromycin in coronavirus patients. Patients confirmed with COVID-19 were included in this single-arm study conducted between early March to March 16th. The study population was administered with 600 mg of hydroxychloroquine daily, 500 mg azithromycin on day 1 and 250 mg per day for the next 4 days was additionally given to six patients. The study endpoint was the status of coronavirus in the patients on Day 6 after inclusion in the study.

In this study, URTI (upper respiratory tract infection) symptoms and LRTI (lower respiratory tract infection) symptoms were present in 22 and 8 patients respectively and 6 patients were asymptomatic. A significant reduction in the viral load was observed in patients as compared to the controls. Addition of azithromycin acted synergistically to hydroxychloroquine for virus elimination.

Even with the small sample size, this study could be considered as a basis for larger COVID-19 treatment clinical trials with hydroxychloroquine and azithromycin.

Source:

International Journal of Antimicrobial Agents

Article:

Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial.

Authors:

Philippe Gautret et al.

Comments (0)

You want to delete this comment? Please mention comment Invalid Text Content Text Content cannot me more than 1000 Something Went Wrong Cancel Confirm Confirm Delete Hide Replies View Replies View Replies en
Try: